Dexlansoprazole [Dexilant™, Dexilant™ SoluTab] – Expanded indication
July 11, 2016 – Takeda announced the FDA approval of dexlansoprazole (Dexilant delayed-release capsules, Dexilant SoluTab orally disintegrating tablets) for the expansion of the current indications to include pediatric patients 12 to 17 years of age.
Top